Jarsin Rx, comprimés pelliculés

7680708220011 CH-70822 Tabletten

Associated product:

JARSIN Rx cpr pellic 60 pce

No image available

Article details

Package size
60
Selling units
60
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
hyperici herbae extractum siccum quantificatum
500.0 MG Substance Wirkstoff (Principe actif)
hypericinum
- Substance WIIS
hyperforinum
- Substance WIIS
cellulosum microcristallinum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
natrium
- Substance HBESI
magnesii stearas
- Substance HNIDK
macrogolum 6000
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
acidum stearicum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
macrogolum 20'000
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK

Authorization holder

OM Pharma Suisse SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
70822
Drug name
Jarsin Rx, comprimés pelliculés
Galenic form
FILM
ATC Code
N06AX25
Authorization status
Z
Authorization category
Category C
Dispensing category
B
First authorization
02/10/2026
Authorization expiration date
31/12/9999
IT Number
01.06.0.
Domain
Human medicine
Field of application
Zur kurzfristigen Behandlung von leichten bis mittelgradigen depressiven Episoden

Package details

Description (FR)
JARSIN Rx cpr pellic 60 pce
Description (DE)
JARSIN Rx Filmtabl 60 Stk
Market launch
30/11/2026
Narcotic (BTM)
No

Other package sizes (1)

JARSIN Rx cpr pellic 30 pce
30 TABL
GTIN: 7680708220028
View
Buy us a coffee Explore the data